Advertisement

Journal of the American Aging Association

, Volume 23, Issue 4, pp 219–225 | Cite as

Growth hormone and aging

  • Andrzej BartkeEmail author
  • Holly Brown-Borg
  • Beth Kinney
  • Julie Mattison
  • Chris Wright
  • Steven Hauck
  • Karen Coschigano
  • John Kopchick
Article

Abstract

The potential usefulness of growth hormone (GH) as an anti-aging therapy is of considerable current interest. Secretion of GH normally declines during aging and administration of GH can reverse age-related changes in body composition. However, mutant dwarf mice with congenital GH deficiency and GH resistant GH-R-KO mice live much longer than their normal siblings, while a pathological elevation of GH levels reduces life expectancy in both mice and men. We propose that the actions of GH on growth, development, and adult body size may serve as important determinants of aging and life span, while the age-related decline in GH levels contributes to some of the symptoms of aging.

Keywords

Growth Hormone Body Size Body Composition Life Span Potential Usefulness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Müller, EE, Celia, SG, De Gennaro Colonna, V, Parenti, M, Cocchi, D, and Locatelli, V: Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals. In: Neurobiology and Neuroendocrinology of Ageing, J. Reprod. Fertil., Suppl. 46:99–114, 1993.Google Scholar
  2. 2.
    D’Costa, AP, Ingram, RL, Lenham, JE, and Sonntag, WE: The regulation and mechanisms of action of growth hormone and insulin-like growth factor I during normal ageing. In: Neurobiology and Neuroendocrinology of Ageing, J. Reprod. Fertil., Suppl. 46: 87–98, 1993.Google Scholar
  3. 3.
    Corpas, E, Harman, SM, and Blackman, MR: Human growth hormone and human aging. Endocr. Rev., 14: 20–39, 1993.PubMedCrossRefGoogle Scholar
  4. 4.
    Strobl, JS, and Thomas, MJ: Human growth hormone. Pharm. Rev., 46: 1–34, 1994.PubMedGoogle Scholar
  5. 5.
    Borst, SE, Millard, WJ, and Lowenthal, DT: Growth hormone, exercise, and aging: the future of therapy for the frail elderly. J. Am. Geriatr. Soc, 42: 528–535, 1994.PubMedGoogle Scholar
  6. 6.
    Giustina, A, and Veldhuis, JD: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev., 19: 717–797, 1998.PubMedCrossRefGoogle Scholar
  7. 7.
    Bartke, A, Brown-Borg, HM, Bode, AM, Carlson, J, Hunter, WS, and Bronson, RT: Does growth hormone prevent or accelerate aging? Experimental Gerontology (Proc. 3rd Int. Symp on Neurbiol and Neuroendocrinol of Aging), 33: 675–687, 1998.Google Scholar
  8. 8.
    Velasco, B, Cacicedo, L, Escalada, J, Lopez-Fernandez, J, and Sanchez-Franko, F: Growth hormone gene expression and secretion in aging rats is age dependent and not age-associated weight increase related. Endocrinology, 139: 1314–1320, 1998.PubMedCrossRefGoogle Scholar
  9. 9.
    Crew, MD, Spindler, SR, Walford, RL, and Koizumi, A: Age-related decrease of growth hormone and prolactin gene expression in the mouse pituitary. Endocrinology, 121: 1251–1255, 1987.PubMedGoogle Scholar
  10. 10.
    Kelijman, M: Age-related alterations of the growth hormone/insulin-like-growth-factor I axis. J. Am. Geriatr. Soc, 39: 295–307, 1991.PubMedGoogle Scholar
  11. 11.
    Tannenbaum, GS: Neuroendocrine control of growth hormone secretion. Acta Paediatr. Scand., 372: 5–16, 1991.CrossRefGoogle Scholar
  12. 12.
    Meites, J. Anti-ageing interventions and their neuroendocrine aspects in mammals. In: Neurobiology and Neuroendocrinology of Ageing, J. Reprod. Fertil., Suppl. 46:1–9, 1993.Google Scholar
  13. 13.
    Sonntag, WE, Cefalu, WT, Ingram, RL, Bennett, SA, Lynch, CD, Cooney, PT, Thornton, PL, and Khan, AS: Pleiotropic effects of growth hormone and insulin-like growth factor (IGF) on biological aging: Inferences from moderate caloric restricted animals. J. Gerontology, 54A: B521–B538, 1999.Google Scholar
  14. 14.
    Baum, HBA, Katznelson, L, Sherman, JC, Biller, BMK, Hayden, DL, Schoenfeld, JC, Cannistraro, KE, and Klibanski, A: Effects of a physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab., 83: 3184–3189, 1998.PubMedCrossRefGoogle Scholar
  15. 15.
    Vance, ME, and Mauras, N: Growth hormone therapy in adults and children. New England J. Med., 341: 1206–1216, 1999.CrossRefGoogle Scholar
  16. 16.
    Rudman, D, Feller, AG, Nagraj, HS, Gergans, GA, Lalitha, PY, Goldberg, AF, Schlenker, RA, Cohn, L, Rudman, IW, and Mattson, DE: Effects of human growth hormone in men over 60 years old. New Engl. J. Med., 323: 1–6, 1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Papadakis, MA, Grady, D, Black, D, Tierney, MJ, Gooding, GA, Schambelan, M, and Grunfeld, C: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann. Intern. Med., 124: 708–716, 1996.PubMedGoogle Scholar
  18. 18.
    Bengtsson, B-Å, Edén, S, Ernest, I, Odén, A, and Sjögren, B: Epidemiology and long-term survival in acromegaly. Acta Med. Scand., 223: 327–335, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Wolf, E, Kahnt, E, Ehrlein, J, Hermanns, W, Brem, G, and Wanke, R: Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models. Mechanisms of Ageing and Development, 68: 71–87, 1993.PubMedCrossRefGoogle Scholar
  20. 20.
    Rollo, CD, Carlson, J, and Sawada, M: Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Can. J. Zool., 74: 606–620, 1996.Google Scholar
  21. 21.
    Orme, SM, McNally, RJQ, Cartwright, RA, and Belchetz, PE: Mortality and cancer incidence in acromegaly: a retrospective cohort study. J. Clin. Endocrinol. Metab., 83: 2730–2734, 1998.PubMedCrossRefGoogle Scholar
  22. 22.
    Yang, C-W, Striker, LJ, Kopchick, JJ, Chen, WY, Pesce, CM, Peten, EP, and Striker, GE: Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene. Kid. Internat., 43: S90–S94, 1993.Google Scholar
  23. 23.
    Pendergast, WR, Li, Y, Jiang, D, and Wolf, NS: Decrease in cellular replicative potential in “ giant” mice transfected with the bovine growth hormone gene correlates to shortened life span. J. Cell. Physiol., 156: 96–103, 1993.CrossRefGoogle Scholar
  24. 24.
    Steger, RW, Bartke, A, and Cecim, M: Premature ageing in transgenic mice expressing growth hormone genes. In: Neurobiology and Neuroendocrinology of Ageing, J. Reprod. Fertil., Suppl. 46: 61–75, 1993.Google Scholar
  25. 25.
    Miller, DB, Bartke, A, and O’Callaghan, JP. Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene. In: Experimental Gerontology, Vol 30, edited by Bartke, A, and Falvo, R, Elsevier Science, Ltd.; 1995: pp. 383–400.Google Scholar
  26. 26.
    Kalu, DN, Orhii, PB, Chen, C, Lee, DY, Hubbard, GB, Lee, S, and Olatunjibello, Y: Aged-rodent models of long-term growth hormone therapy-lack of deleterious effect on longevity. J. Gerontol. Series A-Biological Sciences & Medical Sciences, 53: B452–B643, 1998.Google Scholar
  27. 27.
    Groesbeck, MD, Parlow, AF, and Daughaday, WH: Stimulation of supranormal growth in pubertal, adult plateaued, and hypophysectomized female rats by large doses of rat growth hormone: Physiological effects and adverse consequences. Endocrinology, 120: 1963–1975, 1987.PubMedGoogle Scholar
  28. 28.
    Takala, J, Ruokonen, E, Webster, NR, Nielsen, MS, Zandstra, DF, Vundelinckx, G, and Hinds, CJ: Increased mortality associated with growth hormone treatment in critically ill adults. New Engl. J. Med., 341: 785–792, 1999.PubMedCrossRefGoogle Scholar
  29. 29.
    Larsen, PL, Albert, PS, and Riddle, DL: Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics, 139:1567–1583, 1995.PubMedGoogle Scholar
  30. 30.
    Tatar, M, Khazaeli, AA, and Curtisinger, JW: Chaperoning extended life. Nature, 390: 30, 1997.PubMedCrossRefGoogle Scholar
  31. 31.
    Jazwinski, SM: The genetics of aging in the yeast Saccharomyces cerevisiae. Genetica, 91: 35–51, 1993.PubMedCrossRefGoogle Scholar
  32. 32.
    Brown-Borg, HM, Borg, KE, Meliska, CJ, and Bartke, A: Dwarf mice and the ageing process. Nature, 384: 33, 1996.PubMedCrossRefGoogle Scholar
  33. 33.
    Sornson, MW, Wu, W, Dasen, JS, Flynn, SE, Norman, DJ, O’Connell, SM, Gukovsky, I, Carriére, C, Ryan, AK, and Miller, AP: Pituitary lineage determination by the prophet of Pit1 homeodomain factor defective in Ames dwarfism. Nature, 384: 327–333, 1996.PubMedCrossRefGoogle Scholar
  34. 34.
    Miller, RA: Kleemeier Award Lecture: Are there genes for aging? J. Gerontology: Biological Sci., 54A: B297–B307, 1999.Google Scholar
  35. 35.
    Krzisnik, C, Kolacio, Z, Battelino, T, Brown, M, Parks, JS, and Laron, Z: The “Little People” of the island of Krk-revisited. Etiology of hypopituitarism revealed. J. Endocr. Genetics, 1: 9–19, 1999.Google Scholar
  36. 36.
    Zhou, Y, Xu, BC, Maheshwari, HG, He, L, Reed, M, Lozykowski, M, Okada, S, Wagner, TE, Cataldo, LA, and Coschigano, K: A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (The Laron mouse). Proc. Natl. Acad. Sci. USA, 94: 13215–13220, 1997.Google Scholar
  37. 37.
    Coshigano, KT, Clemmons, D, Bellush, LL, and Kopchick, JJ: Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology, 14: 2608–2613, 2000.CrossRefGoogle Scholar
  38. 38.
    Brown-Borg, HM, Bode, AM, and Bartke, A: Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine, 11: 41–48, 1999.PubMedCrossRefGoogle Scholar
  39. 39.
    Donahue, LR, and Beamer, WG: Growth hormone deficiency in “little” mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2,-1 or-4. J. Endocrinol., 136: 91–104, 1993.PubMedCrossRefGoogle Scholar
  40. 40.
    Hauck, S, and Bartke, A: Effects of growth hormone on hypothalamic Catalase and Cu/Zn superoxide dismutase. Free Radical Medicine & Biology, 28: 970–978, 2000.CrossRefGoogle Scholar
  41. 41.
    Hunter, WS, Croson, WB, Bartke, A, Gentry, MV, and Meliska, CJ: Low body temperature in long-lived Ames dwarf mice at rest and during stress. Physiol. Behav., 67: 433–437, 1999.PubMedCrossRefGoogle Scholar
  42. 42.
    Boettiger, EG: The relation of oxygen consumption and environmental temperature to the growth of dwarf mice. Am. J. Physiol., 129: 312–313, 1940.Google Scholar
  43. 43.
    Borg, KE, Brown-Borg, HM, and Bartke, A: Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc. Soc. Exp. Biol. Med., 210: 126–133, 1995.PubMedGoogle Scholar
  44. 44.
    Winick, M, and Grant, P: Cellular growth in the organs of the hypopituitary dwarf mouse. Endocrinololgy, 83: 544–547, 1968.CrossRefGoogle Scholar
  45. 45.
    Bartke, A. Genetic models in the study of anterior pituitary hormones. In: Genetic Variation in Hormone Systems, edited by Shire, JGM, Boca Raton, CRC Press; 1979: pp. 113–126.Google Scholar
  46. 46.
    Kimura, KD, Tissenbaum, HA, Liu, Y, and Ruvkun, G: daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science, 277: 942–946, 1997.PubMedCrossRefGoogle Scholar
  47. 47.
    Eigenmann, JE, Amador, A, and Patterson, DF: Insulin-like growth factor I levels in proportionate dogs, chondrodystrophic dogs and in giant dogs. Acta Endocrinol., 118: 105–108, 1988.PubMedGoogle Scholar
  48. 48.
    Patronek, GJ, Waters, DJ, and Glickman, LT: Comparative longevity of pet dogs and humans: implications for gerontology research. J. Gerontology, 52A: B171–B178, 1997.Google Scholar
  49. 49.
    Roberts, RC: The lifetime growth and reproduction of selected strains of mice. Heredity, 16: 369–381, 1961.Google Scholar
  50. 50.
    Eklund, J, and Bradford, CE: Longevity and lifetime body weight in mice selected for rapid growth. Nature, 265: 48–49, 1977.PubMedCrossRefGoogle Scholar
  51. 51.
    Samaras, TT, and Elrick, H: Height, body size and longevity. Acta Med Okayama, 53: 149–169, 1999.PubMedGoogle Scholar
  52. 52.
    Maison, P, Balkau, B, Simon, D, Chanson, P, Rosselin, G, and Eschwege, E: Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris pospective study. Brit.Med. J, 316: 1132–1133, 1998.PubMedGoogle Scholar
  53. 53.
    Ultsch, M, and deVos, AM: Crystals of human growth hormone-receptor complexes. Extracellular domains of the growth hormone and prolactin receptors and a hormone mutant designed to prevent dimerization. J. Mol. Biol., 231:1133–1136, 1993.PubMedCrossRefGoogle Scholar
  54. 54.
    Sacca, L, Cittadini, A, and Fazio, S: Growth hormone and the heart. Endocr. Rev., 15: 555–573, 1994.PubMedCrossRefGoogle Scholar

Copyright information

© American Aging Association, Inc. 2000

Authors and Affiliations

  • Andrzej Bartke
    • 1
    Email author
  • Holly Brown-Borg
    • 2
  • Beth Kinney
    • 1
  • Julie Mattison
    • 1
    • 3
  • Chris Wright
    • 1
  • Steven Hauck
    • 1
  • Karen Coschigano
    • 4
  • John Kopchick
    • 4
    • 5
  1. 1.Department of PhysiologySouthern Illinois University, School of MedicineCarbondale
  2. 2.Department of PhysiologyUniversity of North Dakota, School of Medicine, Edwin James Research CenterGrand Forks
  3. 3.Molecular Physiology and Genetics SectionNational Institutes of Health, National Institute on AgingBethesda
  4. 4.Edison Biotechnology InstituteOhio UniversityAthens
  5. 5.Department of Biomedical Sciences, College of Osteopathic MedicineOhio UniversityAthens

Personalised recommendations